Page 2 - Bionxt Solutions Trading News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bionxt solutions trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bionxt Solutions Trading Today - Breaking & Trending Today

BioNxt Solutions Inc.: BioNxt Solutions Acquires Novel Precision Drug Coating and Delivery Technology

VANCOUVER, BC / ACCESSWIRE / March 7, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has signed a definitive technology transfer ....

United States , British Columbia , Dennis Riedl , Hugh Rogers , Bionxt Solutions Inc , Bionxt Solutions Inc View , Bionxt Solutions , North America , Nxt Solutions , Statement Regarding ,

BioNxt Solutions Inc.: BioNxt Solutions Announces Engagement Of Canaccord For Early Warrant Exercise Program

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / March 2, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT) ....

United States , British Columbia , Dennis Riedl , Hugh Rogers , Canaccord Genuity Corp , Bionxt Solutions Inc , Early Warrant Exercise Program , Bionxt Solutions Inc View , Bionxt Science Inc , Company On , Neither The Canadian Securities Exchange , Canadian Securities Exchange , Regulation Services Provider , Bionxt Solutions , Canaccord Genuity , Warrant Exercise , Compensation Warrants , Early Warrant Exercise , Nxt Solutions , North America ,

BioNxt Solutions Inc.: BioNxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson's Disease

VANCOUVER, BC / ACCESSWIRE / March 1, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has executed an agreement to carry out its comparative ....

Baden Wüberg , United States , British Columbia , Dennis Riedl , Hugh Rogers , Bionxt Rotigotine , Wissen Market Research , Bionxt Solutions Inc , Kuick Research , Bionxt Solutions Inc View , Precedence Research , European Medical Agency , Bionxt Solutions , Good Clinical Practice , Vektor Pharma , Nxt Solutions , North America , Statement Regarding ,

BioNxt Solutions Inc.: BioNxt Reports Update on Commercialization of Rotigotine Patch for Treatment of Parkinson's Disease

VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its transdermal ....

Baden Wüberg , United States , British Columbia , Hugh Rogers , Bionxt Rotigotine , Bionxt Solutions Inc , Company Rotigotine , Kuick Research , Bionxt Solutions Inc View , Precedence Research , European Medical Agency , Wissen Market Research , Bionxt Solutions , Vektor Pharma , Good Clinical Practice , Nxt Solutions , North America , Statement Regarding , Marcel Torney ,

BioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Fully Subscribed Private Placement of Convertible Debentures

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / December 7, 2022 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) ....

United States , British Columbia , Hugh Rogers , Company The Units , Bionxt Solutions Inc , Bionxt Solutions Inc View , Bionxt Science Inc , Finder Warrants To Canaccord Genuity Corp , Bionxt Solutions , Principal Amount , Each Unit , Each Warrant , Warrant Share , Canaccord Genuity , Each Finder , United States Securities Act , Nxt Solutions , North America , Statement Regarding ,